Stephanie J. Lee

Research interests

Publications

• Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease

  New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2033122

• Current Use of and Trends in Hematopoietic Cell Transplantation in the United States

  Transplantation and Cellular Therapy · 2020 · 10.1016/j.bbmt.2020.04.013

• Current Use of and Trends in Hematopoietic Cell Transplantation in the United States

  Transplantation and Cellular Therapy · 2020 · 10.1016/j.bbmt.2020.04.013

• EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment

  Bone Marrow Transplantation · 2018 · 10.1038/s41409-018-0204-7

• EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment

  Bone Marrow Transplantation · 2018 · 10.1038/s41409-018-0204-7

• Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation

  New England Journal of Medicine · 2017 · 10.1056/nejmoa1611604

• Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report

  Transplantation and Cellular Therapy · 2015 · 10.1016/j.bbmt.2015.02.025

• Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report

  Transplantation and Cellular Therapy · 2015 · 10.1016/j.bbmt.2015.02.025

• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report

  Transplantation and Cellular Therapy · 2014 · https://doi.org/10.1016/j.bbmt.2014.12.001

• Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

  Transplantation and Cellular Therapy · 2014 · 10.1016/j.bbmt.2014.10.021

• Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

  Transplantation and Cellular Therapy · 2014 · 10.1016/j.bbmt.2014.10.021

• Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors

  New England Journal of Medicine · 2012 · 10.1056/nejmoa1203517

• Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors

  New England Journal of Medicine · 2012 · 10.1056/nejmoa1203517

• Risk factors for acute GVHD and survival after hematopoietic cell transplantation

  Blood · 2011 · 10.1182/blood-2011-06-364265

• Risk factors for acute GVHD and survival after hematopoietic cell transplantation

  Blood · 2011 · 10.1182/blood-2011-06-364265

• Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium

  Blood · 2011 · 10.1182/blood-2010-11-319509

• Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium

  Blood · 2011 · 10.1182/blood-2010-11-319509

• Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria

  Blood · 2011 · https://doi.org/10.1182/blood-2010-08-302109

• High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

  Blood · 2007 · 10.1182/blood-2007-06-097386

• High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

  Blood · 2007 · 10.1182/blood-2007-06-097386

• Histopathologic Diagnosis of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report

  Transplantation and Cellular Therapy · 2006 · 10.1016/j.bbmt.2005.10.023

• American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients

  Journal of Clinical Oncology · 2006 · https://doi.org/10.1200/jco.2006.06.5888

• MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia

  PLoS Medicine · 2006 · https://doi.org/10.1371/journal.pmed.0030270

• Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report

  Transplantation and Cellular Therapy · 2006 · https://doi.org/10.1016/j.bbmt.2006.01.008

• Histopathologic Diagnosis of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report

  Transplantation and Cellular Therapy · 2006 · 10.1016/j.bbmt.2005.10.023

• Rituximab for steroid-refractory chronic graft-versus-host disease

  Blood · 2006 · 10.1182/blood-2006-01-0233

• Rituximab for steroid-refractory chronic graft-versus-host disease

  Blood · 2006 · 10.1182/blood-2006-01-0233

• Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease

  Blood · 2005 · 10.1182/blood-2005-03-1257

• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report

  Transplantation and Cellular Therapy · 2005 · https://doi.org/10.1016/j.bbmt.2005.09.004

• Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease

  Blood · 2005 · 10.1182/blood-2005-03-1257

• Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

  Cancer Cell · 2005 · https://doi.org/10.1016/j.ccr.2005.03.023

• Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age

  Blood · 2005 · https://doi.org/10.1182/blood-2004-05-1947

• Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission

  Blood · 2004 · 10.1182/blood-2004-09-3660

• Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission

  Blood · 2004 · 10.1182/blood-2004-09-3660

• A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

  New England Journal of Medicine · 2003 · https://doi.org/10.1056/nejmoa030288

• Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

  Blood · 2003 · https://doi.org/10.1182/blood-2003-01-0255

• Chronic graft-versus-host disease

  Transplantation and Cellular Therapy · 2003 · 10.1053/bbmt.2003.50026

• Chronic graft-versus-host disease

  Transplantation and Cellular Therapy · 2003 · 10.1053/bbmt.2003.50026

• Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse

  Blood · 2002 · 10.1182/blood.v100.2.406

• Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse

  Blood · 2002 · 10.1182/blood.v100.2.406

• Use of Epoetin in Patients With Cancer: Evidence-Based Clinical Practice Guidelines of the American Society of Clinical Oncology and the American Society of Hematology

  Journal of Clinical Oncology · 2002 · 10.1200/jco.2002.07.177

• Use of Epoetin in Patients With Cancer: Evidence-Based Clinical Practice Guidelines of the American Society of Clinical Oncology and the American Society of Hematology

  Journal of Clinical Oncology · 2002 · 10.1200/jco.2002.07.177

Current projects

No projects listed.